If you've been researching compounded semaglutide, the two questions that matter most are what it actually is and whether the provider behind it is legitimate. Let's break both down.
Quick Answer
Compounded semaglutide is a preparation that contains semaglutide, prepared by a state-licensed 503A compounding pharmacy under an individual prescription from a US-licensed physician. It is not FDA-approved as a final product and is not a generic version of, or interchangeable with, any brand-name medication. Through US telehealth it is typically priced as one all-in monthly amount; the full 2026 numbers are in our compounded semaglutide cost guide.
> Looking for the full picture? Our pillar reference, Compounded Semaglutide: The 2026 Complete Guide, covers cost, safety, dosing, legality, side effects, and how to access it through US telehealth in one place.
What Is Compounded Semaglutide?
Compounded semaglutide contains semaglutide, prepared by a licensed compounding pharmacy for an individual patient. It is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication.
Compounding pharmacies are regulated facilities that create customized medications. In the case of semaglutide, they source ingredients and prepare injectable formulations of semaglutide. Compounded preparations are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with the brand-name product.
Is Compounded Semaglutide Legal?
Yes, within a defined regulatory framework. Under section 503A of the Federal Food, Drug, and Cosmetic Act, state-licensed compounding pharmacies may prepare medication for an individual patient based on a valid prescription from a licensed physician who has determined it is clinically appropriate for that specific patient. These pharmacies must:
- Hold active state pharmacy licenses in the states they serve, under state board of pharmacy oversight
- Compound to United States Pharmacopeia (USP) standards (USP 795 and 797)
- Dispense only against patient-specific prescriptions, not in bulk
- Employ licensed pharmacists who oversee every preparation
Since the FDA resolved the semaglutide shortage in early 2025, compounding rules have tightened: compounded semaglutide may not be simply a copy of the brand product, and the prescribing physician must document the clinical reason it is appropriate for the individual patient. A legitimate provider works only with pharmacies and physicians that follow this framework.
On cost, briefly: at Majesta Health the Essential plan (compounded semaglutide injection) is $179 your first month, then $299 per month, with the physician consultation, medication, ongoing support, and shipping included, and you can cancel anytime. Other US-licensed telehealth providers typically charge $249 to $399 per month all-in, and some offer a lower first-month rate; that range describes the rest of the market, not Majesta's price. For the full 2026 market breakdown, what the price should include, and the fees to watch for, see our dedicated compounded semaglutide cost guide.
What to Look For in a Provider
Not all compounded semaglutide providers are equal. Here's what to verify:
- Licensed physicians. A real licensed doctor should review your case, not an AI chatbot
- Licensed pharmacy partner. Ask which pharmacy dispenses the medication, whether it is state-licensed, and how its preparations are tested
- Transparent pricing. Beware of hidden consultation fees, enrollment charges, or surprise billing
- Ongoing medical supervision. You should have access to your care team throughout treatment
- Third-party testing. Ask the pharmacy to document its potency and sterility testing practices
The Bottom Line
Compounded semaglutide is a cash-pay, physician-prescribed option whose value depends on the provider behind it: the pharmacy, the dose, and the medical oversight. It is not FDA-approved as a final product, and safety and results depend on those same factors. Results may vary.
At Majesta Health, we partner exclusively with a state-licensed 503A compounding pharmacy, and every prescription decision is made by a licensed physician. Our two plans (Essential semaglutide injection from $179 first month, Performance tirzepatide injection from $339 first month) both include the physician consultation, the medication, and discreet shipping. See our pricing for the full breakdown.
Interested in learning more? Start your 2-minute medical assessment to see if you qualify.
Related guides
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider. Individual results may vary.
Related 2026 guides
- 503A pharmacies vs 503B outsourcing facilities: what the letters mean
- Compounded semaglutide cost in 2026
- Can you use HSA or FSA funds for GLP-1 weight loss treatment?
- GLP-1 patches: what is actually inside them
Frequently Asked Questions
What is compounded semaglutide?
Compounded semaglutide is a preparation that contains semaglutide, a GLP-1 receptor agonist, prepared by a state-licensed compounding pharmacy under a US-licensed physician prescription for an individual patient. The active pharmaceutical ingredient (semaglutide) meets United States Pharmacopeia (USP) standards. Compounded versions are formulated as an injection, and some include supportive nutrients as clinically appropriate. Compounded medications are not FDA-approved as final products.
Is compounded semaglutide legal in 2026?
Yes, when prescribed by a US-licensed physician licensed in your state and dispensed by a state-licensed 503A compounding pharmacy following USP 795 and 797 standards, provided all applicable federal and state requirements are met, including restrictions on compounding what is essentially a copy of a commercially available drug. Compounding to meet an individual patient's medical needs is allowed under section 503A of the Federal Food, Drug, and Cosmetic Act. The FDA removed semaglutide from its drug shortage list in early 2025, which tightened compliance requirements for compounding pharmacies. State-licensed compounding pharmacies that hold NABP accreditation and LegitScript certification continue to dispense compounded semaglutide within the regulatory framework.
How much does compounded semaglutide cost?
Compounded semaglutide through US telehealth providers in 2026 typically costs $249 to $399 a month, including physician consultation, medication, and shipping. Some providers offer a lower first-month rate. The main driver of the spread is what the price bundles: consultation, medication, shipping, and ongoing physician access. Insurance rarely applies; compounded preparations are almost always self-pay. Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any brand-name medication.
Is compounded semaglutide as effective as the brand-name product?
Compounded semaglutide contains semaglutide, and so does the brand-name product, but the two are not the same thing and should not be assumed to be equally safe or effective. Compounded semaglutide is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication. Direct head-to-head clinical trials comparing compounded versus brand-name semaglutide do not exist in the published literature, because compounded medications are individualized prescriptions and are not subject to FDA new-drug-application trials. Any outcome depends on the individual patient, the dose, and physician supervision, and individual results vary.
How do I know if a compounded semaglutide provider is legitimate?
Three signals to verify: the prescribing physician must be US-licensed in your state, the compounding pharmacy must hold both NABP accreditation and LegitScript certification, and the platform must operate on a HIPAA-compliant patient portal. Red flags to avoid: any provider selling semaglutide without a physician prescription, pharmacies based outside the United States, sites that skip a real medical assessment, and any provider advertising specific guaranteed weight loss numbers (which violates FTC and FDA advertising rules). LegitScript publishes its certified merchant database publicly for verification.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.USP Compounding Standards (General Chapters 795, 797 and 800) · United States Pharmacopeia
- 2.Digital Pharmacy Accreditation · National Association of Boards of Pharmacy
- 3.Healthcare Merchant Certification · LegitScript
Is this available in your state?
Telehealth rules differ by state, and so does what a physician can prescribe remotely. Each state page covers the local telehealth requirements, whether a video visit is required, and the current status of our physician coverage there.
- California
- Texas
- Florida
- New York
- Pennsylvania
- Illinois
- Ohio
- Georgia
- North Carolina
- Michigan
- Arizona
- Washington
Majesta Health medical content is written against primary sources (FDA labels, peer-reviewed trials, HHS and CDC publications) and passes a documented compliance review before publication. We are rolling out named physician review with US-licensed clinicians from our partner MD Integrations (MDI): each reviewed article will show the reviewing physician's name, NPI, and review date.
- US-licensed physicians affiliated with our clinical partner MD Integrations
- Practicing in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across states planned for launch through the MD Integrations Medical Services Organization (coverage varies by state and clinician licensure; see our states page)
- Dispensing pharmacy partner: Belmar Pharma Solutions; Majesta prescriptions are dispensed through Belmar's state-licensed 503A compounding pharmacy